Mark DePristo is the founder of BigHat Biosciences. BigHat Biosciences has raised $130M in total funding. Backed by Section 32, Andreessen Horowitz, 8VC.
Mark DePristo is the co-founder and founding CEO of BigHat Biosciences, an AI-first antibody design company he launched in 2019. He led the company from seed to Series B, raising over $130M from investors. He stepped down from the CEO role in March 2025.
Full founder directory · Investor directory · Company funding database · Fundraising library